|
CLCN6 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.1814000040219E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.8483000019387E-08 |
| Normal-vs-Stage2 |
1.47419999985132E-07 |
| Normal-vs-Stage3 |
2.44190001552624E-09 |
| Normal-vs-Stage4 |
1.7345000002944E-07 |
| Stage1-vs-Stage2 |
4.258800E-01 |
| Stage1-vs-Stage3 |
2.059200E-01 |
| Stage1-vs-Stage4 |
6.101000E-01 |
| Stage2-vs-Stage3 |
9.036000E-01 |
| Stage2-vs-Stage4 |
8.138400E-01 |
| Stage3-vs-Stage4 |
6.851000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.28719995668081E-09 |
| Normal-vs-AfricanAmerican |
5.995900E-04 |
| Normal-vs-Asian |
5.6093999999951E-05 |
| Caucasian-vs-AfricanAmerican |
3.796400E-01 |
| Caucasian-vs-Asian |
7.744000E-02 |
| AfricanAmerican-vs-Asian |
6.864200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.67309999188348E-09 |
| Normal-vs-Female |
3.13979997557112E-09 |
| Male-vs-Female |
5.228400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.05359999508426E-08 |
| Normal-vs-Age(41-60Yrs) |
1.31329946917447E-10 |
| Normal-vs-Age(61-80Yrs) |
2.88610002563416E-09 |
| Normal-vs-Age(81-100Yrs) |
1.26039999548411E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.364800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.370800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.251820E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.786000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.400460E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.164200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.758800E-03 |
| Classical-VS-Follicular |
3.426600E-01 |
| Classical-VS-Other |
9.701600E-01 |
| Classical-VS-Normal |
7.45099999477361E-08 |
| Tall-VS-Follicular |
7.333900E-02 |
| Tall-VS-Other |
1.740170E-01 |
| Tall-VS-Normal |
2.00499949976063E-10 |
| Follicular-VS-Other |
8.027200E-01 |
| Follicular-VS-Normal |
1.11819999926155E-08 |
| Other-VS-Normal |
2.344000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.8341999858128E-09 |
| Normal-vs-N1 |
1.96630000004472E-06 |
| N0-vs-N1 |
6.061200E-01 |
|
|
